| Nanotechnology‐Based Targeted Drug Delivery: An Emerging Tool to Overcome Tuberculosis Z Baranyai, H Soria‐Carrera, M Alleva, AC Millán‐Placer, A Lucía, ... Advanced Therapeutics, 2000113, 0 | 50 | |
| Controlling properties and cytotoxicity of chitosan nanocapsules by chemical grafting L De Matteis, M Alleva, I Serrano-Sevilla, S García-Embid, G Stepien, ... Marine drugs 14 (10), 175, 2016 | 33 | 2016 |
| Inhibition of p38 MAPK in the brain through nasal administration of p38 inhibitor loaded in chitosan nanocapsules Á Casadomé-Perales, LD Matteis, M Alleva, C Infantes-Rodríguez, ... Nanomedicine 14 (18), 2409-2422, 2019 | 14 | 2019 |
| Remote Activation of Enzyme Nanohybrids for Cancer Prodrug Therapy Controlled by Magnetic Heating B Torres-Herrero, I Armenia, M Alleva, L Asín, S Correa, C Ortiz, ... ACS nano, 2023 | 9 | 2023 |
| Chitosan nanocapsules for the delivery of therapeutic agents I Serrano-Sevilla, S García-Embid, M Alleva, Á Artiga, L Matteis, ... | | 2019 |
| Study of the interaction between polysaccharide nanocapsules and nasal mucosa epithelium for the intranasal administration of drugs for Alzheimer¿ s disease. M Alleva, L Matteis, M Moros, JM Fuente | | 2019 |
| Nanotransportadores basados en nanocápsulas poliméricas I Serrano-Sevilla, S García-Embid, M Alleva, Á Artiga, L Matteis, ... | | 2018 |
| Development of nanotherapeutics for Alzheimer disease based on polysaccharides nanocapsules M Alleva Universidad de Zaragoza, 2017 | | 2017 |
